The prevalence of gestational diabetes mellitus and its related risk factors in Gorgan, north of Iran. Selective or universal screening test is cost-effective? by Mohammadzadeh, F. et al.
Int J Diabetes Dev Ctries (July–September 2015) 35(3):225–229 
DOI 10.1007/s13410-014-0209-8 
ORIGINAL ARTICLE
The prevalence of gestational diabetes mellitus and its related risk 
factors in Gorgan, north of Iran. Selective or universal screening 
test is cost-effective? 
Fatemeh Mohammadzadeh & Samira Eshghinia & 
Mohammad Ali Vakili 
Received: 19 July 2013 /Accepted: 6 May 2014 /Published online: 9 January 2015 
# Research Society for Study of Diabetes in India 2015 
Abstract Gestational diabetes mellitus (GDM) is the most 
prevalent metabolic disorder in pregnancy. GDM is defined in 
<1 % to 28 % of pregnancies, depending on the diagnostic 
criteria, the ethnic and racial characteristics. This study was 
performed to determine the prevalence of GDM and related 
risk factors among pregnant women in Gorgan, north of Iran. 
In a cross sectional study, 1276 pregnant women were recruit-
ed. All of women screened with glucose challenge test (GCT) 
in 24–28th wks of gestational age. Women with positive GCT 
underwent 100 g glucose tolerance test (OGTT). Diagnosis of 
GDMwas according to Carpenter and Coustan’s criteria. GCT 
was positive in 200 women (15.8 % with CI: 13.8 %–17.8 %) 
and GDM was diagnosed in 62 case (4.9 % with CI:3.7 %– 
6.8 %). In a multiple logistic regression, risk factors such as 
age, BMI, history of macrosomia, familial history of diabetes 
and impaired fasting glucose (IFG) were identified as inde­
pendent risk factors for GDM (p<0.05). Among GDM cases, 
3.2 %(2 women) had no risk factor. These results show 
moderate prevalence of GDM in north of Iran. It seems that 
a selective GDM screening method for women with some risk 
factors is more appropriate than general screening. 
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Introduction 
Gestational diabetes mellitus (GDM) is a metabolic disorder, 
defined as carbohydrate intolerance with first onset or diag­
nose in pregnancy. A resent systematic review on the preva­
lence of GDM with a focus on advanced economies reported 
the prevalence of GDM with a range of 1.7–11.6 %[1]. In 
another review, in 173 countries, GDM prevalence estimated 
range from <1% to 28%, depending on the diagnostic criteria 
used and the ethnic and racial characteristics [2]. GDM in­
creases the risk of mortality and morbidity rate for both 
mother and child during pregnancy. The related complications 
of GDM include fetal macrosomia, birth trauma, intra-uterine 
fetal death (IUFD), neonatal hypoglycemia, risk of childhood 
obesity and type 2 diabetes [3, 4]. Pregnant womenwith GDM 
also are at increased risk of caesarean section, gestational 
hypertension, hydramnios, stillbirth and development of type 
2 diabetes in future [5, 6]. Because of the lack of clinical signs 
and symptoms of GDM, screening tests are recommended 
during pregnancy to early detection [7]. The two major rec­
ommended methods for screening are universal and selective 
screening based on risk factors. However universal screening 
is more sensitive, selective screening is cost-effective [8]. 
There are only little data on the prevalence of GDM and its 
risk factors in Iranian population. The aim of this study is to 
estimate the GDM prevalence and its related risk factors in 
eastern north of Iran. 
Methodology 
A cross-sectional study carried out in a teaching hospital and 
primary health centers in Gorgan City (Golestan state in east 
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of Caspian Sea, Iran) from March 2011 to September 2012. 
The screening and diagnosis of GDM have remained con­
troversial. Since 2011 the ADA recommended single 75 gr 
OGTT at 24–28 weeks of pregnancy as screening and 
diagnostic test for GDM [9]. In the time that study was 
carried, in Iran, except some of research centers, Glucose 
Challenge Test (GCT) and OGTT 100 gr were used for 
universal screening. 
Data collection 
A total of 1276 eligible pregnant women were randomly 
recruited into the study. Pregnant women with preexisting 
diabetes mellitus, twin pregnancies, miscarriage or termina­
tion before 24 weeks of gestational age and those on steroid 
therapy were excluded. 
At the first antenatal visit, a structured questionnaire was 
administered to obtain baseline information data such as age, 
parity, gestational age. Participant’s weight (before 12 weeks), 
height and blood pressure were measured, body mass index 
(BMI) was calculated. If the pregnant woman had at least one 
of the risk factors of GDM, early screening in the first visit 
was performed. Risk factors for GDM which we used as a 
guide for early screening were: age >35 years, BMI >30 kg/ 
m2, familial history of diabetes, macrosomia, congenital 
malformations, stillbirth or unexplained abortion, history of 
IFG, GDM and preeclampsia [9, 10]. Some of those who had 
negative GCT followed by repeated test in 24–28 weeks. For 
cases without risk factors, the screening test was done at 24– 
28 weeks. Serum glucose value >130 mg/dl on GCT, 
underwent a 100 g 3 h OGTT after an overnight 8 h fasting. 
The diagnosis of GDM was based on the criteria of Car­
penter and Coustan [11], when at least two of the four values 
were raised: fasting >95 mg/dl, 1 h >180 mg/dl, 2 h >155 mg/ 
dl and 3 h >140 mg/dl. If only one of four samples was 
impaired, OGTT was repeated 4 weeks later. 
Statistical Analysis 
In this cross-sectional analysis, Mean ± SD are presented 
and compared using Students T-test for continuous, χ2 
test or Fisher exact test for categorical variables. The 
binary logistic regression was used to assess the strength 
of association between dependent and independent vari­
ables. Odds ratio (OR) and CI were calculated in logistic 
regression analysis. Forward stepwise multiple logistic 
regression analysis was used to test several models for 
the association of gestational diabetes mellitus and other 
variables. All analyses were performed with the SPSS 
version16. Statistical level of significance was set at 0.05 
and 95 % confidence interval (CI) was calculated. 
Table 1 The baseline characteristics of the study population (n=1,276) 
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Ethical consideration 
This study was approved by the “Research Deputy” and 
research ethics committee of the Golestan University of Med­
ical sciences. A written consent form was signed by each 
participant. Women with GDM referred to endocrinologist 
and nutritionist for management and medical nutrition 
therapy. 
Results 
The study included 1276 pregnant women aged 16–51 years. 
The 297 (23.3 %) and 965 (75.6 %) of them were from rural 
and urban population respectively and 14 (1.1 %) was data 
missing. Table 1 shows the baseline characteristics of the 
subjects. 
Two hundred (15.7 % CI13.8–17.8 %) of the women had a 
positive GCT. GDM was diagnosed in 62 women or 4.9 % (CI 
3.7–6.8 %). In rural and urban population, GDM defined in 
Table 2 Distribution of gestational diabetes cases according to demo­
graphic and medical variables 
P- value non- GDM GDM Risk factors 
0.001 27.1±5.4 30.16±4.8 Age (year) 
NS 159.8±5.9 158.7±5.5 Height (Cm) 
0.0001 64.2±13.2 73±12.1 Weight (kg) 
0.001 25.1±4.8 29±4.8 BMI (kg/m2) 
NS 4.6±1.8 1.3±2.1 Parity 
0.02 104.7±10.3 107.6±9.7 Systolic BP (mmHg) 
NS 66.2±8 66.8±8 Diastolic BP (mmHg) 
0.002 0.3 4.8 History of GDM (%) 
NS 0.6 0 History of gestational HTN 
0.001 16.9 35.5 Family history of diabetes (%) 
0.001 0.9 9.7 History of macrosomia (%) 
NS 14.2 21 History of abortion and still birth 
(%) 
NS 0.3 0 Previous congenital malformation 
(%) 
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Table 3 Most significant predictors associated with GDM using multiple 
logistic regression analysis 
P- value CI OR Risk factors 
0.006 1.147–1.023 1.083 Age 
0.001 1.145–1.044 1.093 BMI 
NS 1.078–0.94 1.007 Parity 
NS 1.059–0.992 1.025 Systolic BP 
NS 1.019–0.933 0.975 Diastolic BP 
0.01 33.454–1.624 7.371 History of impaired fasting glucose 
NS 20.305–0.50 3.186 History of GDM 
0.029 3.708–1.073 1.994 Family history of diabetes 
0.001 33.906–2.581 9.355 History of macrosomia 
4.4 % and 5.1 % respectively, that was not statistically signif­
icant (P=0.37).  
The mean age was 30.1±4.82 years in women with GDM 
and 27.1±5.47 years in non GDM subjects (p=0.0001).  
The mean BMI of GDM and normal subjects were 29.01± 
4.80 and 25.09±4.83 kg/m2 respectively (p=0.0001).  
In univariate analysis of related risk factors maternal age, 
weight, systolic blood pressure and familial history of diabe­
tes, history of IFG, fetal macrosomia, GDM in previous 
pregnancy were significantly associated with a higher likeli­
hood for GDM (P<0.05). Table 2 shows the comparison of 
risk factors on binary logistic analysis in with GDM and non 
GDM women. 
However in a multiple logistic regression history of fetal 
macrosomia, familial history of diabetes, IFG, maternal age 
and BMI were identified as independent risk factors for GDM 
(p<0.05) (Table 3) .  
We also study the GDM prevalence in different age and 
BMI groups. In the age group less than 20 years GDMwas not 
detected. The most prevalence of GDM (8.8 %) was seen in 
group of women equal or more than 35 years old (Table 4).We 
consider the 20–24 year age group as the reference group. 
Risk of GDM in age ≥35 years is 4.4 (95 %CI 1.7–11.4) times 
greater than 20–24 years. Instead of every one year increase 
for age, risk of GDM will raise 1.083 (95 % CI 1.023–1.147) 
fold. 
We evaluate the prevalence of GDM in normal weight, 
overweight and obese women based on BMI. 669 (53.3 %) 
of our population had normal BMI (BMI <25) and rest of 
them were overweight (BMI between 25 to 29.99) or obese 
(BMI ≥30). In normal weight subjects, GDM was seen in 14 
(2.1 %). In 392 overweight subjects, prevalence of GDM was 
5.4 %. 195 subjects (15.5 %) were obese that 27 women 
(13.8 %) diagnosed as GDM. Risk of GDM in women with 
BMI ≥30 was 4.7 (CI 2.79–8.03) times greater than subjects 
with BMI <30. Every one unit rising in BMI increases risk of 
GDM 1.1 fold (CI: 1–1.15). 
Discussion 
The prevalence of GDM was 4.9 % in our population, that is 
conformably to other parts of world [2]. In the another studies 
prevalence of GDM was 4 % in USA [12] and 2–6 % in  
Europe population with high prevalence in the south of Med­
iterranean [13]. The prevalence varies between racial and 
ethnic groups within the same country [14]. 
In a study in different parts of Iran, the prevalence was 1.3– 
8.9 %[15]. The highest prevalence (8.9 %) was reported from 
Bandar Abbas in south of Iran, screening and diagnostic 
criteria was performed as same as our method. This difference 
may be related to higher prevalence of type 2 diabetes in this 
area. [16]. Lowest prevalence reported from Ardebil in West 
North of Iran (1.7%) [17] that may be due to upper level of cut 
off point for GCT (140 mg/dl). 
A few study in Iran investigated GDM risk factors. In this 
study, we consider the risk factors for GDM. 
According to greatest available evidence, the established 
risk factors for GDM are maternal age, increased body fat 
mass, race, family history of diabetes, history of IFG and 
macrosomia, about other risk factors such as parity, hyperten­
sion and history of poor obstetric outcomes, available data is 
controversial [12]. Our study shows that maternal age, BMI, 
familial history of diabetes, history of IFG and macrosomia 
were independent risk factors for GDM. The high relative risk 
was belong to history of macrosomia and IFG. 
Maternal age more than 25 years is an important risk factor 
of GDM [18]. In age group <20 years, we didn’t see GDM. 
The most prevalence of GDM was seen in group of women 
≥35 years old. In our sample, risk of GDM in age ≥35 years is 
4.4 times greater than 20–24 years. In a study in Isfahan- Iran, 
Table 4 Odds ratio for Age-ad­
justed prevalence of GDM Age groups GDM Non GDM Total OR CI P-value 
<20 0 (0) 87 (100) 87 (100) − − −
20–24 7 (2.1) 322 (97.9) 329 (100) 1 − −
25–29 24 (5.9) 383 (94.1) 407 (100) 2.883 1.226–6.777 .015 
30–34 19 (6.5) 275 (93.5) 294 (100) 3.178 1.316–7.673 .010 
≥ 35 12 (8.8) 125 (91.2) 137 (100) 4.416 1.700–11.473 .002 
Total 62 (4.9) 1192 (95.1) 1254 (100) — .020 
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the prevalence of GDM in age <20 year was zero. The relative 
risk of GDM in women ≥35 years was 10.2 times greater than 
women who had 20–24 years [18] and in another study in 
south of Iran, this was 15 fold [16]. 11.3 % women with GDM 
in our research were in group <25 years. Therefore, if we did 
selective screening based on age groups, we missed remark­
able cases of GDM. 
In many studies, BMI more than 30 kg/m2 was related with 
incidence of GDM [16, 19, 20], in our study prevalence of 
GDMwas 13.8 % in women with BMI ≥30 and 3.3 % in BMI 
<30 (p<0.001). Risk of GDM in women with BMI ≥30 was 
4.7 times greater than subjects with BMI <30. 
In normal weight subjects, GDM prevalence was 1.1 %. 
According to this finding, it’s probable that screening based 
on BMI (BMI >25 kg/m2) will be cost  effective.  
The association of positive familial history with GDM in 
our population was according to results in most previous 
studies [13, 21, 22], but some study such as a research in 
Nigeria and another in Seri- Lanka didn’t find this relationship  
[19, 20]. Its discordant results were probably due to the shorter 
duration of the study and/or influenced by unknown con­
founding factors in the study population [20]. 
Although other risk factors such as parity, maternal hyper­
tension and history of poor obstetric outcomes in our study 
were not statistically different in GDM and non GDM groups, 
this findings are consistent with those of Ardabil, in west north 
[17], Ahvaz, in the south [23], Tehran in the center [21] of Iran  
and in other countries such as Seri Lanca [19]. In our subjects 
with GDM, 2 women (3.2 %) were without any risk factors. 
Conclusion 
The best approach to screen for GDM remains a controversy. 
The American Diabetes Association (2011), recommended 
universal screening, however selective screening is more 
cost-effective in low-prevalence populations. With due atten­
tion to moderate prevalence of GDM in our population, it 
seems that selective screening based on some risk factors such 
as BMI >25 is wisely approach and more cost effective. 
Limitations of our study 
We didn’t note the mother’s weight gain during pregnancy and 
lipid profile that could be a risk factor for GDM. We also 
didn’t follow the women to determine maternal and newborns 
pregnancy outcomes. 
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